317 results on '"Khoo, Bernard"'
Search Results
2. Adrenal Vein Sampling: Does the Location of the Non-adrenal Venous Sample Matter?
3. Author Correction: Targeting the incretin system in obesity and type 2 diabetes mellitus
4. Chronic treatment with glucagon-like peptide-1 and glucagon receptor co-agonist causes weight loss-independent improvements in hepatic steatosis in mice with diet-induced obesity
5. Genetic disorders and hypoparathyroidism: unravelling complexity through case studies
6. Society for Endocrinology guidelines for the diagnosis and management of post-bariatric hypoglycaemia
7. GLP-1 analogue therapy for obesity in people from Asia
8. Adaptive infusion of a glucagon‐like peptide‐1/glucagon receptor co‐agonist G3215, in adults with overweight or obesity: Results from a phase 1 randomized clinical trial
9. Increased glycemic variability in pregnant women with Roux-en-Y gastric bypass compared with sleeve gastrectomy
10. Effect of Opioids on Adrenal and Reproductive Endocrinology
11. Call for prospective studies of continuous glucose monitoring to define the glycaemic response to bariatric surgery
12. Sleeve gastrectomy causes weight‐loss independent improvements in hepatic steatosis
13. Uncovering the Rare: Managing a case of 'Cushing's Crisis'
14. Gestational thyrotoxicosis due to molar pregnancy complicated by pre-eclampsia
15. Adrenocortical Carcinoma presenting as florid Cushing's Syndrome
16. Assessment of Practice around Corticosteroid Sick Day Rules in Transplant and Oncology Services of a Tertiary Hospital in UK
17. 177Lu DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) in advanced Phaeochromocytomas and paragangliomas (PPGL) - a single centre experience at a ENETS Centre of Excellence
18. Commentary on “The road to reliable peptide assays is paved with good guidelines”
19. The postprandial secretion of peptide YY1‐36 and 3‐36 in obesity is differentially increased after gastric bypass versus sleeve gastrectomy.
20. The postprandial secretion of peptide YY 1‐36 and 3‐36 in obesity is differentially increased after gastric bypass versus sleeve gastrectomy
21. Mechanisms and regulation of RNA polymerase III transcription initiation
22. Carney-Stratakis Syndrome Caused by a Novel SDHD Mutation
23. Genetic therapies to lower cholesterol
24. Acute hypoglycemia as the presenting manifestation secondary to pituitary metastasis in a patient with malignant melanoma
25. Letter to the editor of clinical endocrinology: Assessment of adrenal function in patients who survive COVID‐19
26. Pseudohypoparathyroidism presenting with extensive bone lytic lesion histology proven Brown tumours
27. Cushing[rdquo]s crises arising from a neuroendocrine tumour treated with etomidate infusion
28. Pituitary Apoplexy presenting with acute hyponatraemia
29. Ockham’s razor for a retinal lesion and acromegaly and breaking the vicious circle
30. Redefining the stress cortisol response to surgery
31. Steps to redressing an imbalance: GLP-1 analogues for obesity in east Asia
32. A Comparison of the Blood Glucose, Growth Hormone, and Cortisol Responses to Two Doses of Insulin (0.15 U/kg vs. 0.10 U/kg) in the Insulin Tolerance Test: A Single-Centre Audit of 174 Cases
33. Peptide Receptor Radionuclide Treatment and (131)I‐MIBG in the management of patients with metastatic/progressive phaeochromocytomas and paragangliomas
34. Preserved C ‐peptide in survivors of COVID ‐19: Post hoc analysis
35. Surpassing insulin glargine in type 2 diabetes with tirzepatide
36. Pituitary and gonadal axes in patients with ’Long COVID’: post hoc analysis
37. Pregnancy and neuroendocrine neoplasms
38. Metastatic Medullary Thyroid Cancer: The Role of 68Gallium-DOTA-Somatostatin Analogue PET/CT and Peptide Receptor Radionuclide Therapy
39. Real-life experience of tolvaptan use in the treatment of severe hyponatraemia due to syndrome of inappropriate antidiuretic hormone secretion
40. Tirzepatide and the new era of twincretins for diabetes
41. Phaeochromocytomas and Paragangliomas: A difference in disease behaviour and clinical outcomes
42. Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers
43. Normal Adrenal and Thyroid Function in Patients Who Survive COVID-19 Infection
44. Weight Loss With a Novel Peptide YY Analogue for Obesity: A Randomised, Placebo-Controlled Phase I Trial
45. Thyroid Function Before, During and After COVID-19
46. Letter to the editor of clinical endocrinology: Assessment of adrenal function in patients who survive COVID‐19.
47. Molecular Cloning of the Transcription Factor TFIIB Homolog from Sulfolobus shibatae
48. Multicentre study of investigation and management of inpatient hyponatraemia in the UK
49. Differential effects of bile acids on the postprandial secretion of gut hormones: a randomized crossover study
50. Misleading 68 GALLIUM‐dotatate PET scan in a patient with a history of a phaeochromocytoma: Unsuspected uptake in papillary thyroid carcinoma metastases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.